Uncontrolled maternal chronic respiratory diseases in pregnancy: A new potential risk factor suggested to be associated with anorectal malformations in offspring. Issue 2 (19th December 2018)

• Record Type: Journal Article
• Authors: van de Putte, Romy; de Blaauw, Ivo; Boenink, Rianne; Reijers, Monique H.E.; Broens, Paul M.A.; Sloots, Cornelius E.J.; van Heijst, Arno F.J.; van Gelder, Marleen M.H.J.; Roeleveld, Nel; van Rooij, Iris A.L.M.
• Is Part Of: Birth defects research. Volume 111:Issue 2(2019)
• Page Start: 62
• Page End: 69
• Publication Date: 2018-12-19
• Subjects: anal atresia -- anti‐asthmatic drugs -- congenital malformations -- pregnancy -- uncontrolled asthma; Teratology -- Periodicals; Abnormalities, Human -- Periodicals; Congenital Abnormalities; Embryo, Mammalian -- abnormalities; Teratology; Abnormalities, Human; Teratology; Periodicals; Periodicals; 616.043
• DOI: 10.1002/bdr2.1429
• Languages: English
• ISSNs: 2472-1727

Abstract

Abstract : Background: Chronic respiratory diseases and use of antiasthmatic medication during pregnancy may both play a role in the etiology of congenital anorectal malformations (ARM). However, it is unclear, whether the medication use or the underlying condition would be responsible. Therefore, our aim was to unravel the role of maternal chronic respiratory diseases from that of antiasthmatic medication in the etiology of ARM. Methods: We obtained 412 ARM patients and 2, 137 population‐based controls from the Dutch AGORA data‐ and biobank. We used maternal questionnaires and follow‐up telephone interviews to obtain information on chronic respiratory diseases, antiasthmatic medication use, and potential confounders. Multivariable logistic regression analyses were performed to estimate odds ratios (ORs) with 95% confidence intervals (95% CI). RESULTS: We observed higher risk estimates among women with chronic respiratory diseases with and without medication use (1.4 [0.8–2.7] and 2.0 [0.8–5.0]), both in comparison to women without a chronic respiratory disease and without medication use. Furthermore, increased ORs of ARM were found for women using rescue medication (2.4 [0.8–7.3]) or a combination of maintenance and rescue medication (2.5 [0.9–6.7]). In addition, increased risk estimates were observed for women having nonallergic triggers (2.5 [1.0–6.3]) or experiencing exacerbations during the periconceptional period (3.5 [1.4–8.6]). CONCLUSIONS: Although the 95% CIs of most associations include the null value, the risk estimates all point towards an association between uncontrolled chronic respiratory disease, instead of antiasthmatic medication use, with ARM in offspring. Further in‐depth studies towards mechanisms of this newly identified risk factor are warranted.